We are live on ! Find out more
EW icon

Edwards Lifesciences
EW

1,320 hedge funds and large institutions have $66.6B invested in Edwards Lifesciences in 2021 Q4 according to their latest regulatory filings, with 207 funds opening new positions, 461 increasing their positions, 417 reducing their positions, and 95 closing their positions.

New
Increased
Maintained
Reduced
Closed

118% more first-time investments, than exits

New positions opened: 207 | Existing positions closed: 95

29% more funds holding in top 10

Funds holding in top 10: 21 → 27 (+6)

15% more capital invested

Capital invested by funds: $58.1B → $66.6B (+$8.54B)

11% more repeat investments, than reductions

Existing positions increased: 461 | Existing positions reduced: 417

8% more funds holding

Funds holding: 1,227 → 1,320 (+93)

5% more call options, than puts

Call options by funds: $250M | Put options by funds: $239M

0.1% more ownership

Funds ownership: 82.42% → 82.53% (+0.1%)

Holders
1,320
Holders Change
+93
Holders Change %
+7.58%
% of All Funds
20.31%
Holding in Top 10
27
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+28.57%
% of All Funds
0.42%
New
207
Increased
461
Reduced
417
Closed
95
Calls
$250M
Puts
$239M
Net Calls
+$11.5M
Net Calls Change
-$23.2M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$467M
2
Brown Advisory
Brown Advisory
Maryland
+$297M
3
UBS AM
UBS AM
Illinois
+$256M
4
N
Nuveen
North Carolina
+$179M
5
Capital International Investors
Capital International Investors
California
+$146M

Top Sellers

Rank Fund Capital Flow
1
Capital Research Global Investors
Capital Research Global Investors
California
-$573M
2
Wells Fargo
Wells Fargo
California
-$328M
3
Winslow Capital Management
Winslow Capital Management
Minnesota
-$261M
4
JSP
Jackson Square Partners
California
-$132M
5
SFFS
Stonehage Fleming Financial Services
Jersey
-$121M
Name Holding Trade Value Shares
Change 		Change in
Stake
RA
1401
Resolute Advisors
California
– -$18K -161 Closed
MA
1402
MCF Advisors
Kentucky
– -$15K -133 Closed
ACM
1403
Anfield Capital Management
California
– -$12K -105 Closed
RCG
1404
Rock Creek Group
District of Columbia
– -$12K -105 Closed
CFA
1405
Cahill Financial Advisors
Minnesota
– -$11K -100 Closed
AWA
1406
Arkadios Wealth Advisors
Georgia
– -$9K -84 Closed
RTL
1407
Red Tortoise LLC
Georgia
– -$7K -81 Closed
BMD
1408
Better Money Decisions
New Mexico
– -$7K -62 Closed
PP
1409
Pacifica Partners
Canada
– -$7K -57 Closed
CWM
1410
Cranbrook Wealth Management
Michigan
– -$5K -45 Closed
CA
1411
Crewe Advisors
Utah
– -$3K -30 Closed
GC
1412
Globeflex Capital
California
– -$3K -27 Closed
HFM
1413
Hartford Financial Management
Connecticut
– -$2K -20 Closed
RG
1414
Retirement Group
California
– +$117 +1 New
SAM
1415
Strategic Asset Management
Minnesota
– +$350 +3 New
53 54 55 56
57

EW Hedge Fund Activity: Q4 2021 in Review

1,320 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Edwards Lifesciences (EW) for Q4 2021, worth a combined $66.6B — up 15% from $58.1B a quarter earlier.

Buyers outnumbered sellers: 207 funds opened new EW positions and 95 closed out — a net gain of 112 holders — while 461 added to existing stakes and 417 trimmed.

The largest buyer was BlackRock, adding an estimated $467M. The largest seller was Capital Research Global Investors, cutting an estimated $573M.

  • 1,320 institutional investors held Edwards Lifesciences (EW) as of Q4 2021, up from 1,227 in Q3 2021.
  • Funds reported $66.6B of Edwards Lifesciences stock for Q4 2021, up 15% quarter-over-quarter.
  • 207 funds opened new Edwards Lifesciences positions in Q4 2021 and 95 closed out, a net change of +112 holders.
  • The largest Edwards Lifesciences buyer in Q4 2021 was BlackRock, an estimated $467M added.
  • The largest Edwards Lifesciences seller in Q4 2021 was Capital Research Global Investors, an estimated $573M sold.

Based on aggregated 13F filings for Q4 2021.